• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    EBMT-EHA
    CAR T-Cell Meeting
    2019
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

high-risk

2:24
Better together? Ibrutinib and venetoclax for high-risk CLL
Nitin Jain
1:53
Nivolumab with ibrutinib for Richter’s transformation
Nitin Jain
2:33
Treatment options for high-risk myeloma
Annemiek Broyl
1:56
How do we define a ‘cure’ in myeloma?
Annemiek Broyl
2:48
MRD and disease eradication in myeloma
Jesús San Miguel
1:59
Smoldering multiple myeloma: what is the current definition & new screening programme
Irene Ghobrial
2:32
Improving the treatment landscape for DLBCL patients
Andrés Ferreri
2:14
How to define and treat high-risk lymphoma
Andrés Ferreri
1:58
Logistics for a technique to avoid GvHD
Denis C. Roy
1:56
Implications for a technique which eliminates GvHD
Denis C. Roy
2:08
Eradicating GvHD after haploidentical stem cell transplant
Denis C. Roy
1:05
When is the use of MRD appropriate?
Rafael Fonseca
1:06
Response to MM therapy can vary based on a variety of factors
Shaji Kumar
3:12
Prognostic indices for follicular lymphoma: PRIMA-PI
Marek Trneny
3:17
Improving outcomes after transplant in AML
Charles Craddock
3:02
New technologies informing SOC in DLBCL
Christian Gisselbrecht
  • 1
  • 2
  • 3
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use